Myocardial Viability Imaging: Does It Still Have a Role in Patient Selection Prior to Coronary Revascularisation?

Suchi Grover, Govin Srinivasan, Joseph B. Selvanayagam

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Patients with severe left ventricular (LV) dysfunction and multi-vessel coronary artery disease (CAD) are at high risk during revascularisation, however they are also likely to derive the most benefit. Historically, the detection of dysfunctional but potentially viable myocardium ('stunned or hibernating myocardium') has been central to the decision-making regarding revascularisation. A number of recent studies have challenged this paradigm, questioning the role of viability testing in this population. In this review, we will examine the position of viability testing and how it is best incorporated in the modern era of coronary revascularisation. We will outline the role of currently available imaging modalities in viability assessment. Myocardial viability testing will continue to play a role in revascularisation decisions, although larger randomised trials with clinical outcome end-points are needed to further define its role.

LanguageEnglish
Pages468-479
Number of pages12
JournalHeart Lung and Circulation
Volume21
Issue number8
DOIs
Publication statusPublished - 1 Jan 2012

Keywords

  • Coronary revascularisation
  • Hibernating myocardium
  • Myocardial viability

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

@article{bb813a8a2e844ea3bbf6eb66414323d9,
title = "Myocardial Viability Imaging: Does It Still Have a Role in Patient Selection Prior to Coronary Revascularisation?",
abstract = "Patients with severe left ventricular (LV) dysfunction and multi-vessel coronary artery disease (CAD) are at high risk during revascularisation, however they are also likely to derive the most benefit. Historically, the detection of dysfunctional but potentially viable myocardium ('stunned or hibernating myocardium') has been central to the decision-making regarding revascularisation. A number of recent studies have challenged this paradigm, questioning the role of viability testing in this population. In this review, we will examine the position of viability testing and how it is best incorporated in the modern era of coronary revascularisation. We will outline the role of currently available imaging modalities in viability assessment. Myocardial viability testing will continue to play a role in revascularisation decisions, although larger randomised trials with clinical outcome end-points are needed to further define its role.",
keywords = "Coronary revascularisation, Hibernating myocardium, Myocardial viability",
author = "Suchi Grover and Govin Srinivasan and Selvanayagam, {Joseph B.}",
year = "2012",
month = "1",
day = "1",
doi = "10.1016/j.hlc.2012.03.008",
language = "English",
volume = "21",
pages = "468--479",
journal = "Heart, lung & circulation",
issn = "1443-9506",
publisher = "Wiley-Blackwell",
number = "8",

}

Myocardial Viability Imaging : Does It Still Have a Role in Patient Selection Prior to Coronary Revascularisation? / Grover, Suchi; Srinivasan, Govin; Selvanayagam, Joseph B.

In: Heart Lung and Circulation, Vol. 21, No. 8, 01.01.2012, p. 468-479.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Myocardial Viability Imaging

T2 - Heart, lung & circulation

AU - Grover, Suchi

AU - Srinivasan, Govin

AU - Selvanayagam, Joseph B.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Patients with severe left ventricular (LV) dysfunction and multi-vessel coronary artery disease (CAD) are at high risk during revascularisation, however they are also likely to derive the most benefit. Historically, the detection of dysfunctional but potentially viable myocardium ('stunned or hibernating myocardium') has been central to the decision-making regarding revascularisation. A number of recent studies have challenged this paradigm, questioning the role of viability testing in this population. In this review, we will examine the position of viability testing and how it is best incorporated in the modern era of coronary revascularisation. We will outline the role of currently available imaging modalities in viability assessment. Myocardial viability testing will continue to play a role in revascularisation decisions, although larger randomised trials with clinical outcome end-points are needed to further define its role.

AB - Patients with severe left ventricular (LV) dysfunction and multi-vessel coronary artery disease (CAD) are at high risk during revascularisation, however they are also likely to derive the most benefit. Historically, the detection of dysfunctional but potentially viable myocardium ('stunned or hibernating myocardium') has been central to the decision-making regarding revascularisation. A number of recent studies have challenged this paradigm, questioning the role of viability testing in this population. In this review, we will examine the position of viability testing and how it is best incorporated in the modern era of coronary revascularisation. We will outline the role of currently available imaging modalities in viability assessment. Myocardial viability testing will continue to play a role in revascularisation decisions, although larger randomised trials with clinical outcome end-points are needed to further define its role.

KW - Coronary revascularisation

KW - Hibernating myocardium

KW - Myocardial viability

UR - http://www.scopus.com/inward/record.url?scp=84863844167&partnerID=8YFLogxK

U2 - 10.1016/j.hlc.2012.03.008

DO - 10.1016/j.hlc.2012.03.008

M3 - Review article

VL - 21

SP - 468

EP - 479

JO - Heart, lung & circulation

JF - Heart, lung & circulation

SN - 1443-9506

IS - 8

ER -